GENE ONLINE|News &
Opinion
Blog

2018-05-17|

May 17, 2013: Dr. Janet Rowley Received Albany Medical Center Prize in Medicine and Biomedical Research

by GeneOnline
Share To

On May 17, 2013, American geneticist Janet Rowley was awarded the Albany Medical Center Prize in Medicine and Biomedical Research which was an important indicator of being regarded for the Nobel Prize. Rowley’s award-winning study shown that chronic myeloid leukemia cells have abnormal recombination on it chromosome 22, which in turn produces Bcr-Abl mutant kinases. This study was the foundation of developing the first drug (Imatinib) for targeted therapy in the world.

Reference
http://articles.chicagotribune.com/2013-04-17/news/ct-met-janet-rowley-prize-20130417_1_albany-medical-center-prize-leukemia-gleevec

Image Source
https://www.timesunion.com/local/article/Lowering-the-cost-of-saving-lives-4527098.php#photo-4645736

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Fifth HIV Patient Cured After Stem Cell Transplant in Germany
2023-03-01
R&D
First Sustainable Chromosome Changes in Mammals
2022-09-01
R&D
Are iPSCs safe? Nearly 75% of Skin Stem Cells Have Severe DNA Damage from UV Exposure
2022-08-29
LATEST
Cortisol: New Discoveries on its Impact Across Health, Culture, and Evolution
2024-02-26
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
EVENT
Scroll to Top